Is olanzapine better than haloperidol in resistant schizophrenia? A double-blind study in partial responders

Author： Altamura A.C   Velonà I   Curreli R   Mundo E   Bravi D  

Publisher： Ashgate Publishing Ltd

ISSN： 1365-1501

Source： International Journal of Psychiatry in Clinical Practice, Vol.6, Iss.2, 2002-06, pp. : 107-111

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Amisulpride has a superior benefit/risk profile to haloperidol in schizophrenia: results of a multicentre, double-blind study - (the Amisulpride Study Group*

By Carriere P.   Bonhomme D.   Lemperiere T.  

European Psychiatry, Vol. 15, Iss. 5, 2000-08 ,pp. : 321-329

Elsevier

Access to resources Recommend Favorite

Double-blind substitution of vigabatrin and valproate in carbamazepine-resistant partial epilepsy

By Brodie M.J.   Mumford J.P.  

Epilepsy Research, Vol. 34, Iss. 2, 1999-04 ,pp. : 199-205

Elsevier

Access to resources Recommend Favorite

Conjugated estrogens as adjuvant therapy in the treatment of acute schizophrenia: a double-blind study

By Louza M.R.   Marques A.P.   Elkis H.   Bassitt D.   Diegoli M.   Gattaz W.F.  

Schizophrenia Research, Vol. 66, Iss. 2, 2004-02 ,pp. : 97-100

Elsevier

Access to resources Recommend Favorite

Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy

By Sharief M.   Viteri C.   Ben-Menachem E.   Weber M.   Reife R.   Pledger G.   Karim R.  

Epilepsy Research, Vol. 25, Iss. 3, 1996-11 ,pp. : 217-224

Elsevier

Access to resources Recommend Favorite

Efficacy and safety of Losigamone in partial seizures: a randomized double-blind study

By Baulac M.   Klement S.   Losigamone Study Group  

Epilepsy Research, Vol. 55, Iss. 3, 2003-08 ,pp. : 177-189

Elsevier

Access to resources Recommend Favorite